[144] Equifax, Incorporated SEC Filing
Form 144 notice by an Equifax insider to sell common stock. The filer intends to sell 4,553 shares of Equifax common stock through Fidelity Brokerage Services on the NYSE, with an aggregate market value reported as $1,111,895.40 and total shares outstanding listed as 123,797,380. The securities to be sold derive from stock options granted on 11/01/2019 (722 shares) and 09/28/2018 (3,831 shares); payment is shown as cash and the approximate date of sale is 08/29/2025. The filing indicates no securities were sold by the reporting person in the past three months and includes the standard representation that the seller knows of no undisclosed material adverse information about the issuer.
Avviso Form 144: un dirigente di Equifax intende vendere azioni ordinarie. Il dichiarante prevede di vendere 4.553 azioni ordinarie Equifax tramite Fidelity Brokerage Services sul NYSE, con un valore di mercato complessivo indicato di $1.111.895,40 e un totale di azioni in circolazione pari a 123.797.380. I titoli provengono da opzioni su azioni concesse il 01/11/2019 (722 azioni) e il 28/09/2018 (3.831 azioni); il pagamento è in contanti e la data approssimativa della vendita è il 29/08/2025. La comunicazione segnala che la persona interessata non ha venduto titoli nei tre mesi precedenti e include la dichiarazione standard che il venditore non è a conoscenza di informazioni materiali avverse non divulgate sull'emittente.
Aviso Formulario 144: un insider de Equifax pretende vender acciones ordinarias. El declarante tiene la intención de vender 4.553 acciones ordinarias de Equifax a través de Fidelity Brokerage Services en la NYSE, con un valor de mercado agregado reportado de $1.111.895,40 y un total de acciones en circulación de 123.797.380. Los valores a vender proceden de opciones sobre acciones otorgadas el 01/11/2019 (722 acciones) y el 28/09/2018 (3.831 acciones); el pago se realizará en efectivo y la fecha aproximada de la venta es el 29/08/2025. La presentación indica que la persona informante no vendió valores en los tres meses anteriores e incluye la declaración estándar de que el vendedor no conoce información adversa material no divulgada sobre el emisor.
Form 144 통지: Equifax 내부자가 보통주를 매각하려� 합니�. 신고인은 NYSE에서 Fidelity Brokerage Services� 통해 Equifax 보통� 4,553주를 매각� 예정이며, � 시장 가치는 $1,111,895.40으로 보고되었� � 발행 주식수는 123,797,380주로 기재되어 있습니다. 매도 대� 증권은 2019� 11� 1� 부여된 주식매수선택�(722�)� 2018� 9� 28� 부여된 선권(3,831�)에서 유래합니�; 결제� 현금으로 이루어지� 대략적� 매각 예정일은 2025� 8� 29일입니다. 제출 서류� 신고인이 지� 3개월 동안 증권� 매도하지 않았음을 밝히� 있으�, 판매자가 발행인에 대� 공개되지 않은 중대� 불리� 정보� 알고 있지 않다� 표준 진술� 포함합니�.
Avis Formulaire 144 : un initié d'Equifax prévoit de vendre des actions ordinaires. Le déclarant a l'intention de vendre 4 553 actions ordinaires Equifax via Fidelity Brokerage Services sur le NYSE, pour une valeur marchande agrégée signalée de 1 111 895,40 $ et un total d'actions en circulation de 123 797 380. Les titres à vendre proviennent d'options sur actions attribuées le 01/11/2019 (722 actions) et le 28/09/2018 (3 831 actions) ; le paiement sera en espèces et la date approximative de vente est le 29/08/2025. Le dépôt indique que la personne déclarante n'a pas vendu de titres au cours des trois derniers mois et inclut la déclaration standard selon laquelle le vendeur n'a connaissance d'aucune information défavorable importante non divulguée concernant l'émetteur.
Form 144-Mitteilung: Ein Insider von Equifax beabsichtigt den Verkauf von Stammaktien. Der Einreicher beabsichtigt, 4.553 Equifax-Stammaktien über Fidelity Brokerage Services an der NYSE zu verkaufen, mit einem angegebenen Gesamtmarktwert von $1.111.895,40 und insgesamt 123.797.380 ausstehenden Aktien. Die zu verkaufenden Wertpapiere stammen aus Aktienoptionen, die am 01.11.2019 (722 Aktien) und am 28.09.2018 (3.831 Aktien) gewährt wurden; die Zahlung erfolgt in bar und das ungefähre Verkaufsdatum ist der 29.08.2025. Die Meldung weist darauf hin, dass die meldende Person in den letzten drei Monaten keine Wertpapiere verkauft hat, und enthält die übliche Erklärung, dass der Verkäufer keine nicht offengelegten, wesentlichen negativen Informationen über den Emittenten kenne.
- Required disclosure provided showing broker, share count, aggregate value, and acquisition details
- No reported sales in prior three months, simplifying aggregation considerations under Rule 144
- Insider proposes to sell 4,553 shares with an aggregate market value of $1,111,895.40
- The filing does not state whether the sale is part of a Rule 10b5-1 trading plan
Insights
TL;DR: Insider plans to sell 4,553 shares (~$1.11M) via Fidelity on the NYSE; sale stems from prior option grants.
The filing is a routine Rule 144 notice disclosing a proposed sale of Equifax common stock totaling 4,553 shares with an aggregate market value of $1,111,895.40. The securities originate from options granted in 2018 and 2019 and are to be sold for cash. The document reports no sales in the prior three months, which may be relevant when aggregating permitted sales under Rule 144, but the filing itself provides no explanation of intent or timing beyond the approximate sale date of 08/29/2025. For investors, this is a disclosure of an insider liquidity event; the filing contains no financial performance data or new issuer-specific developments.
TL;DR: Proper Rule 144 procedure appears followed; disclosure lists option origins and brokerage channel.
The notice supplies required information: class of shares, broker name and address, number of shares, aggregate market value, acquisition dates and nature (options granted), and representation regarding material non-public information. The filing does not state whether the sale is part of a trading plan or related to Rule 10b5-1, though it references the trading-plan representation text. From a governance standpoint, the form meets disclosure obligations but contains no additional governance or related-party detail.
Avviso Form 144: un dirigente di Equifax intende vendere azioni ordinarie. Il dichiarante prevede di vendere 4.553 azioni ordinarie Equifax tramite Fidelity Brokerage Services sul NYSE, con un valore di mercato complessivo indicato di $1.111.895,40 e un totale di azioni in circolazione pari a 123.797.380. I titoli provengono da opzioni su azioni concesse il 01/11/2019 (722 azioni) e il 28/09/2018 (3.831 azioni); il pagamento è in contanti e la data approssimativa della vendita è il 29/08/2025. La comunicazione segnala che la persona interessata non ha venduto titoli nei tre mesi precedenti e include la dichiarazione standard che il venditore non è a conoscenza di informazioni materiali avverse non divulgate sull'emittente.
Aviso Formulario 144: un insider de Equifax pretende vender acciones ordinarias. El declarante tiene la intención de vender 4.553 acciones ordinarias de Equifax a través de Fidelity Brokerage Services en la NYSE, con un valor de mercado agregado reportado de $1.111.895,40 y un total de acciones en circulación de 123.797.380. Los valores a vender proceden de opciones sobre acciones otorgadas el 01/11/2019 (722 acciones) y el 28/09/2018 (3.831 acciones); el pago se realizará en efectivo y la fecha aproximada de la venta es el 29/08/2025. La presentación indica que la persona informante no vendió valores en los tres meses anteriores e incluye la declaración estándar de que el vendedor no conoce información adversa material no divulgada sobre el emisor.
Form 144 통지: Equifax 내부자가 보통주를 매각하려� 합니�. 신고인은 NYSE에서 Fidelity Brokerage Services� 통해 Equifax 보통� 4,553주를 매각� 예정이며, � 시장 가치는 $1,111,895.40으로 보고되었� � 발행 주식수는 123,797,380주로 기재되어 있습니다. 매도 대� 증권은 2019� 11� 1� 부여된 주식매수선택�(722�)� 2018� 9� 28� 부여된 선권(3,831�)에서 유래합니�; 결제� 현금으로 이루어지� 대략적� 매각 예정일은 2025� 8� 29일입니다. 제출 서류� 신고인이 지� 3개월 동안 증권� 매도하지 않았음을 밝히� 있으�, 판매자가 발행인에 대� 공개되지 않은 중대� 불리� 정보� 알고 있지 않다� 표준 진술� 포함합니�.
Avis Formulaire 144 : un initié d'Equifax prévoit de vendre des actions ordinaires. Le déclarant a l'intention de vendre 4 553 actions ordinaires Equifax via Fidelity Brokerage Services sur le NYSE, pour une valeur marchande agrégée signalée de 1 111 895,40 $ et un total d'actions en circulation de 123 797 380. Les titres à vendre proviennent d'options sur actions attribuées le 01/11/2019 (722 actions) et le 28/09/2018 (3 831 actions) ; le paiement sera en espèces et la date approximative de vente est le 29/08/2025. Le dépôt indique que la personne déclarante n'a pas vendu de titres au cours des trois derniers mois et inclut la déclaration standard selon laquelle le vendeur n'a connaissance d'aucune information défavorable importante non divulguée concernant l'émetteur.
Form 144-Mitteilung: Ein Insider von Equifax beabsichtigt den Verkauf von Stammaktien. Der Einreicher beabsichtigt, 4.553 Equifax-Stammaktien über Fidelity Brokerage Services an der NYSE zu verkaufen, mit einem angegebenen Gesamtmarktwert von $1.111.895,40 und insgesamt 123.797.380 ausstehenden Aktien. Die zu verkaufenden Wertpapiere stammen aus Aktienoptionen, die am 01.11.2019 (722 Aktien) und am 28.09.2018 (3.831 Aktien) gewährt wurden; die Zahlung erfolgt in bar und das ungefähre Verkaufsdatum ist der 29.08.2025. Die Meldung weist darauf hin, dass die meldende Person in den letzten drei Monaten keine Wertpapiere verkauft hat, und enthält die übliche Erklärung, dass der Verkäufer keine nicht offengelegten, wesentlichen negativen Informationen über den Emittenten kenne.